NCT05093803 is a NA clinical trial of CONTROL GROUP in Hypertension, sponsored by University of Alicante.

Who is sponsoring NCT05093803?

NCT05093803 is sponsored by University of Alicante.

What drugs are being tested in NCT05093803?

Interventions in NCT05093803: CONTROL GROUP, HEALTH APP GROUP.

What condition does NCT05093803 study?

NCT05093803 studies Hypertension, Diet, Healthy, Body Weight, Obesity, Cholesterol; Lipidosis, Machine Learning.

Is NCT05093803 still recruiting?

NCT05093803 is currently completed. Last updated 3 October 2022.

Last reviewed 2022-10-03 · How we verify

NCT05093803

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improvement of Physical and Physiological Parameters Through the Use of a Mobile App

Completed NA Last updated 3 October 2022

What this trial tests

NA trial testing CONTROL GROUP in Hypertension in 70 participants. Completed in 30 December 2021.

Timeline

1 July 2020

Primary endpoint
30 December 2021

30 December 2021

Quick facts

Lead sponsor	University of Alicante
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	single
Primary purpose	prevention
Enrollment	70
Start date	1 July 2020
Primary completion	30 December 2021
Estimated completion	30 December 2021
Sites	1 location across Spain

Drugs / interventions tested

CONTROL GROUP — full drug profile →
HEALTH APP GROUP

Conditions studied

Hypertension — all drugs for Hypertension →
Diet, Healthy — all drugs for Diet, Healthy →
Body Weight — all drugs for Body Weight →
Obesity — all drugs for Obesity →

Sponsor

University of Alicante

Who can join

21 and older, any sex, with Hypertension or Diet, Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the health effects of a new mobile application (app) for prevention and personalized treatment in people with chronic cardiovascular pathologies associated with body composition.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Digital health technologies and artificial intelligence in cardiovascular clinical trials: A landscape of the European space.
Lampreia F, Madeira C, Dores H. · · 2024 · cited 4× · PMID 39291150 · DOI 10.1177/20552076241277703
Effectiveness of App-Based Intervention to Improve Health Status of Sedentary Middle-Aged Males and Females.
Martínez-Olcina M, Cuestas-Calero BJ, Miralles-Amorós L, Vicente-Martínez M, et al · · 2022 · cited 1× · PMID 35627392 · DOI 10.3390/ijerph19105857

Verify or expand the search:

Other trials of CONTROL GROUP

Trials testing the same drug.

NCT07189845 — Effect of BIS-Guided Anesthesia on Postoperative Nausea and Vomiting in Pediatric Patients · NA · completed
NCT06337929 — Effects of Capoeira on the Physical and Psychological Performance of Adults · NA · unknown
NCT06188806 — Investigation of the Effect of Proximal and Distal Adductor Canal Block in Knee Replacement Surgery · NA · recruiting
NCT05763238 — Exercise Training in Children With Corrective Cardiac Surgeries · NA · completed
NCT04539873 — Impact of Colchicine in Hospitalized Colombian Patients With COVID-19 · Phase 3 · terminated

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other University of Alicante trials

Trials by the same sponsor.

NCT07385794 — Design and Validation of a Personalized Preventive System for Adolescents Based on Biological Maturity, Body Composition · NA · not yet recruiting
NCT06240364 — Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome · NA · not yet recruiting
NCT07104669 — Sports Nutrition Assessment Program · not yet recruiting
NCT07531953 — Nutritional Knowledge and Characteristics of HYROX Athletes · recruiting
NCT07269821 — Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Bo · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05093803 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alicante
Last refreshed: 3 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05093803.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing